Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

International journal of oncology - 1 Jun 2017

Yanokura Megumi, Banno Kouji, Adachi Masataka, Aoki Daisuke, Abe Kuniya

Abstract excerpt

Aberrant DNA methylation is widely observed in many cancers. Concurrent DNA methylation of multiple genes occurs in endometrial cancer and is referred to as the CpG island methylator phenotype (CIMP). However, the features and causes of CIMP-positive endometrial cancer are not well understood. To investigate DNA methylation features characteristic to CIMP-positive endometrial cancer, we first classified samples...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli Protein
Share to Antigens, CD

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cadherins

Share to CpG Islands

Share to Endometrial Neoplasms

Share to Epigenesis, Genetic

Share to MicroRNAs

Share to MutL Protein Homolog 1

Source

Open in PubMed Open full text

Identifiers

PMID: 28440489
DOI: 10.3892/ijo.2017.3966
PMCID: PMC5435325

Genes

APC
CDH1
MLH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.PMID 28440489Read ↗

Status and significance of CpG island methylator phenotype in endometrial cancer.Semantic proximity Read ↗

Identification of endometrial cancer methylation features using combined methylation analysis methods.Semantic proximity Read ↗

Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.Semantic proximity Read ↗

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.Semantic proximity Read ↗

Biological significance of the CpG island methylator phenotype.Semantic proximity Read ↗

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.Semantic proximity Read ↗

The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer.Semantic proximity Read ↗

Unique DNA methylome profiles in CpG island methylator phenotype colon cancers.Semantic proximity Read ↗

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological dataSemantic proximity Read ↗

Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.Semantic proximity Read ↗

Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?Semantic proximity Read ↗

Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.